Medtronic Statement Regarding U.S. Supreme Court’s Favorable Decision In Riegel V. Medtronic, Inc.

The U.S. Supreme Court ruled 8 to 1 today in favor of Medtronic (NYSE:MDT) in Riegel v. Medtronic, Inc. The decision reaffirms that the U.S. Food and Drug Administration (FDA) pre-market approval process for medical devices, which expertly balances the patient benefits and risks, appropriately preempts state tort lawsuits involving devices approved through that process.

More: continued here

Filed under: Medical Malpractice / Litigation on February 26th, 2008